Wis. Admin. Code Department of Children and Families DCF 154.02

Current through September 30, 2024
Section DCF 154.02 - Definitions

In this chapter:

(1) "Administering agency" has the meaning given in s. 49.162(1) (a), Stats.
(2) "Confirmation test" means an analytical procedure used to quantify a specific controlled substance or its metabolite in a specimen through a test that is different in scientific principle from that of the initial test procedure and capable of providing requisite specificity, sensitivity, and quantitative accuracy to positively determine use of a controlled substance.
(3) "Controlled substance" or "substance" has the meaning given for "controlled substance" in s. 961.01(4), Stats.
(4) "Department" means the department of children and families.
(4m) "Medical review officer" means a licensed physician employed by or providing services under contract to a drug testing vendor who has knowledge of substance abuse disorders and laboratory testing procedures and who has the necessary training and experience to interpret and evaluate a person's positive test result in relation to that person's medical history and current valid prescriptions.
(5) "Metabolite" means a chemical present in the body when a controlled substance is being broken down through natural metabolic processes that can be detected or measured as a positive indicator that a controlled substance associated with the metabolite has been used.
(7) "Person" means a parent who is not a custodial parent under s. 767.55(2) (a), Stats., who has been ordered by the court pursuant to s. 767.55(2) (am), Stats., to participate in a work experience and job training program under s. 49.36, Stats.
(8) "Reasonable suspicion" means suspicion of controlled substance abuse by a person based on that person's score on a screening questionnaire.
(9) "Screening" means completion of a questionnaire regarding the person's current and prior use of controlled substances.
(10) "Specimen" means tissue, fluid, or a product of the human body capable of revealing the presence of controlled substances or their metabolites.
(11) "Treatment" means services that are conducted under clinical supervision to assist a person through the process of recovery from controlled substance abuse and may include screening for abuse of controlled substances, application of approved placement criteria, intake, orientation, assessment, individualized treatment planning, intervention, individual or group and family counseling, referral, discharge planning, after care or continuing care, recordkeeping, consultation with other professionals regarding the patient's treatment, recovery and case management, crisis intervention, client education, employment, and problem resolution in life skills functioning.
(12) "Treatment program" means a program certified to provide treatment for controlled substance abuse as a medically managed inpatient service under s. DHS 75.10, a medically monitored treatment service under s. DHS 75.11, a day treatment service under s. DHS 75.12, an outpatient treatment service under s. DHS 75.13, a transitional residential treatment service under s. DHS 75.14, or a narcotic treatment service for opiate addiction under s. DHS 75.15.
(13) "Treatment provider" or "provider" means a provider of treatment for controlled substance abuse certified by the department of health services under the provisions of ch. DHS 75.
(14) "Work experience program" or "program" means a work experience program for noncustodial parents under s. 49.36, Stats.

Wis. Admin. Code Department of Children and Families DCF 154.02

Adopted by, EmR1612: emerg. cr. eff. 3-17-16; CR 16-022: cr. Register July 2016 No. 727, eff. 8-1-16; (6) renum. to (4m) under s. 13.92(4) (b) 1, Stats., Register July 2016 No. 727, eff.8/1/2016